2014-10-01

Philips Launches Wearable Blue LED Light Therapy Device to Treat Skin Disease

Royal Philips (NYSE:PHG, AEX:PHIA), the global leader in lighting, today announces the launch of Philips BlueControl, a clinically tested1,5 wearable medical device2 that uses blue LED light to control mild to moderate cases of psoriasis vulgaris. Philips BlueControl will be introduced to international healthcare professionals at the European Academy of Dermatology & Venereology (EADV) Congress (8th - 12th October) in Amsterdam. It will be prescribed by physicians and available through distributors in The Netherlands, Germany and The UK from October 2014.
Continue reading
2014-06-19

Korean Institute IBS Uses Blue LED Light to Control Cell Protein Functions

Researchers at the Institute for Basic Science (IBS) in South Korea have succeeded in developing the world’s first technology to control specific protein functions in living cells by using lights, which may be useful in future cancer cell research.
Continue reading
2008-10-28

Backward - Looking OSRAM’s Outstanding LED projects

OSRAM have undertaken outstanding projects that demonstrates the wide range of colours available, their versatility, their compact size and ease of installation given to architects, designers and installers. All this offers freedom to devise completely new lighting solutions, some of which can be incredibly creative and dramatic. Below are four examples of outstanding LED projects.  1. OSRAM LED sculpture welcomes visitors to London Heathrow's Terminal 5
Continue reading

Violumas, provider of high-power UV LED solutions and inventor of 3-PAD LED technology, is proud to launch the release of new 275nm and 265nm LEDs in mid-power, high-power, and high-density packages. The radiant flux of the new 275nm and 265nm... READ MORE

DURHAM, NC – November 12, 2024 –– Cree LED, a Penguin Solutions brand (Nasdaq: PENG), today announced the launch of its new CV28D LEDs with FusionBeam™ Technology, a groundbreaking advancement for the LED signage market... READ MORE